Biologics, Inc. (NC) Selected By Ariad Pharmaceuticals, Inc. To Be The Exclusive Specialty Pharmacy Provider For Iclusig (Ponatinib)

Published: Jan 13, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARY, N.C.--(BUSINESS WIRE)--Biologics, Inc., an integrated oncology services company, is pleased to announce that it has been selected by ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) to be the sole specialty pharmacy provider of Iclusig® (ponatinib) and manager of its Patient Access and Support Services (ARIAD PASSTM) program. Iclusig is a treatment for adult patients with refractory chronic myeloid leukemia or Philadelphia-chromosome positive (Ph+) acute lymphoblastic leukemia.

Help employers find you! Check out all the jobs and post your resume.

Back to news